Recombinant IGF1R (Teprotumumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IGF1R (Teprotumumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This IGF1R (Teprotumumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Teprotumumab Biosimilar - Anti-IGF1R, CD221 mAb
- Characteristics
- Antibody Type: IgG1-nd
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1
-
anti-IGF1R (Teprotumumab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade Reactivity: Human FACS Host: Human Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- IGF1R (Teprotumumab Biosimilar)
- Target Type
- Biosimilar
- Background
-
RO4858696-000
Teprotumumab is a biosimilar directed against the extracellular domain of IGF-I R/IGF1R. - CAS-No
- 1036734-93-6
-
You are here:
